Luis Diaz is a prominent figure in oncology, currently serving as the Head of the Division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center since December 2016. In addition to this role, Diaz is a member of the Board of Directors for Quest Diagnostics and has held advisory and board positions for various organizations, including PetDx, Jounce Therapeutics, and the American Association for Cancer Research. As a co-founder of innovative companies such as Pagerbox, Personal Genome Diagnostics, and PapGene, Diaz has significantly contributed to advancements in cancer diagnostics and treatment. Diaz's academic background includes a Fellowship in Medical Oncology and a residency in Internal Medicine from The Johns Hopkins University School of Medicine, complemented by an M.D. from the University of Michigan Medical School and a B.S. in Microbiology from the University of Michigan.
This person is not in any teams
This person is not in any offices
Memorial Sloan Kettering Cancer Center
9 followers
The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world’s most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years.